Siddhartha S Saha1, Nyssa B Samanas1, Irina Miralda1, Nicholas J Shubin1, Kerri Niino1, Gauri Bhise1, Manasa Acharya1, Albert J Seo1, Nathan Camp1, Gail H Deutsch2, Richard G James3, Adrian M Piliponsky4. 1. Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash. 2. Department of Laboratories, Seattle Children's Research Institute, Seattle, Wash; Department of Pathology, University of Washington School of Medicine, Seattle, Wash. 3. Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash; Department of Pediatrics, University of Washington School of Medicine, Seattle, Wash. 4. Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash; Department of Pediatrics, University of Washington School of Medicine, Seattle, Wash; Department of Pathology, University of Washington School of Medicine, Seattle, Wash; Department of Global Health, University of Washington School of Medicine, Seattle, Wash. Electronic address: adrian.piliponsky@seattlechildrens.org.
Abstract
BACKGROUND: Mast cells are involved in many distinct pathologic conditions, suggesting that they recognize and respond to various stimuli and thus require a rich repertoire of cell surface proteins. However, mast cell surface proteomes have not been comprehensively characterized. OBJECTIVE: We aimed to further characterize the mast cell surface proteome to obtain a better understanding of how mast cells function in health and disease. METHODS: We enriched for glycosylated surface proteins expressed in mouse bone marrow-derived cultured mast cells (BMCMCs) and identified them using mass spectrometry analysis. The presence of novel surface proteins in mast cells was validated by real-time quantitative PCR and flow cytometry analysis in BMCMCs and peritoneal mast cells (PMCs). We developed a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene editing approach to disrupt genes of interest in BMCMCs. RESULTS: The glycoprotein enrichment approach resulted in the identification of 1270 proteins in BMCMCs, 378 of which were localized to the plasma membrane. The most common protein classes among plasma membrane proteins were small GTPases, receptors, and transporters. One such cell surface protein was CD98 heavy chain (CD98hc), encoded by the Slc3a2 gene. Slc3a2 gene disruption resulted in a significant reduction in CD98hc expression, adhesion, and proliferation. CONCLUSIONS: Glycoprotein enrichment coupled with mass spectrometry can be used to identify novel surface molecules in mast cells. Moreover, CD98hc plays an important role in mast cell function.
BACKGROUND: Mast cells are involved in many distinct pathologic conditions, suggesting that they recognize and respond to various stimuli and thus require a rich repertoire of cell surface proteins. However, mast cell surface proteomes have not been comprehensively characterized. OBJECTIVE: We aimed to further characterize the mast cell surface proteome to obtain a better understanding of how mast cells function in health and disease. METHODS: We enriched for glycosylated surface proteins expressed in mouse bone marrow-derived cultured mast cells (BMCMCs) and identified them using mass spectrometry analysis. The presence of novel surface proteins in mast cells was validated by real-time quantitative PCR and flow cytometry analysis in BMCMCs and peritoneal mast cells (PMCs). We developed a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene editing approach to disrupt genes of interest in BMCMCs. RESULTS: The glycoprotein enrichment approach resulted in the identification of 1270 proteins in BMCMCs, 378 of which were localized to the plasma membrane. The most common protein classes among plasma membrane proteins were small GTPases, receptors, and transporters. One such cell surface protein was CD98 heavy chain (CD98hc), encoded by the Slc3a2 gene. Slc3a2 gene disruption resulted in a significant reduction in CD98hc expression, adhesion, and proliferation. CONCLUSIONS: Glycoprotein enrichment coupled with mass spectrometry can be used to identify novel surface molecules in mast cells. Moreover, CD98hc plays an important role in mast cell function.
Authors: Cristina Teodosio; Andrés C García-Montero; María Jara-Acevedo; Laura Sánchez-Muñoz; Carlos E Pedreira; Ivan Álvarez-Twose; Sergio Matarraz; José M Morgado; Paloma Bárcena; Almudena Matito; Andrea Mayado; Maria Luz Sanchez; María Diez-Campelo; Luis Escribano; Alberto Orfao Journal: J Allergy Clin Immunol Date: 2013-02-10 Impact factor: 10.793
Authors: Ching-Cheng Chen; Michele A Grimbaldeston; Mindy Tsai; Irving L Weissman; Stephen J Galli Journal: Proc Natl Acad Sci U S A Date: 2005-07-08 Impact factor: 11.205
Authors: Qingbo Li; Chinnaswamy Jagannath; Prahlad K Rao; Christopher R Singh; Giovanni Lostumbo Journal: Proteomics Date: 2010-11 Impact factor: 3.984
Authors: Manuel Stemmer; Thomas Thumberger; Maria Del Sol Keyer; Joachim Wittbrodt; Juan L Mateo Journal: PLoS One Date: 2015-04-24 Impact factor: 3.240